🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out if removing a specific type of whi...
Status
Terminated
Location
Memorial SloanKettering Cancer Center
Start Date
2018-07-23
Trial ID
NCT03615144
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
With this protocol the ALL-SCT BFM international study group wants * to ev...
Status
Unknown
Location
Universitätsklinik für Kinder- und Jugendheilkunde, Klin. Abt. f. Hämato-Onkologie
Start Date
2007-01
Trial ID
NCT01423500
Human phenylketonuria (PKU) results from phenylalanine hydroxylase (PAH) de...
Status
Terminated
Location
UPMC Children's Hospital of Pittsburgh
Start Date
2011-10-12
Trial ID
NCT01465100
This research study is assessing the feasibility of reduced intensity allog...
Status
Withdrawn
Location
Massachusetts General Hospital
Start Date
2017-05
Trial ID
NCT02724904
Treatments Being Tested
The primary objective of this study is to compare the 2-year progression fr...
Status
Unknown
Location
Saint Louis hospital
Start Date
2017-11-20
Trial ID
NCT03250546
Treatments Being Tested
Transplant rejection occurs when a patient's body does not recognize the ne...
Status
Completed
Location
University of Wisconsin - Department of Medicine
Start Date
2003-11
Trial ID
NCT00078559
This phase II trial investigates how well a naive T cell depleted graft wor...
Status
Not Yet Recruiting
Location
Seattle Children's Hospital
Start Date
2026-09
Trial ID
NCT07660783
Treatments Being Tested
Prognosis of patients with graft failure is dismal, and re-transplantation ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2021-12-01
Trial ID
NCT05126186
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-07
Trial ID
NCT00027560